EP4429693
MONOMERIC ANNEXIN A5 FOR USE IN THE TREATMENT OF MACULAR OEDEMA OR RETINAL VEIN OCCLUSION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.5.2023EP published:
26.2.2025EP application number:
23730718.6
EPO information:
European Patent Register
Max expiry date:
17.5.2043
Title in English:
MONOMERIC ANNEXIN A5 FOR USE IN THE TREATMENT OF MACULAR OEDEMA OR RETINAL VEIN OCCLUSIONLanguage of the patent:
English
Timeline
Today
18.5.2023EP application
26.2.2025EP Publication
Owner
Name:
Annexin Pharmaceuticals ABAddress:
Kammakargatan 48, 111 60 Stockholm, SE
Inventor
Name:
FROSTEGÅRD, AnnaAddress:
11160 Stockholm, SE
Name:
HAEGERSTRAND, AndersAddress:
11160 Stockholm, SE
Priority
Number:
202207263Date:
18.5.2022Country:
GB
Classification
Categories:
A61K 38/17, A61P 27/02